Ornim, headquartered in Santa Clarita, CA, has received FDA clearance for the firm’s CerOx 3210F system to be used to monitor blood flow through tissue in adult patients. This clearance is on top of the one received in 2008 for hemoglobin oxygen saturation monitoring in the brain and skeletal muscles. According to the company, the light based system is the only non-invasive and continuous blood flow monitor available.
From the technology page:
Ornim’s patented UTL
ightTM technology employs the interaction of light and sound to provide a non-invasive measure of blood oxygen saturation. UTLight technology is unique among all other commercially available NIRS products, as it confines the measurement to a well-defined sample volume and is mostly unaffected by such factors as skin pigmentation.
Benefits of UTLight technology:
• Universal measurement of oxygen saturation levels regardless of individual patients characteristics such as skin type or blood volume
• Simultaneous, yet independent measure of blood oxygen saturation and flow
• Direct measurement of blood flow
• Quantitative, real-time, and non-invasive
FDA approval letter: Ornim, Inc. announces FDA Clearance For Brain Oximetry and Blood Flow Monitoring for the CerOx 3210F Monitor… (.pdf)
Product page: CerOx monitor…
Flashbacks: Ornim Oxygen Saturation System FDA Approved; OrNim’s Targeted Oximetry